Tuesday, Aug 11, 2020 | Last Update : 04:34 PM IST

140th Day Of Lockdown

Maharashtra52451335842118050 Tamil Nadu3028752446755041 Andhra Pradesh2355251456362116 Karnataka182354991263312 Delhi1461341316574131 Uttar Pradesh126722767212120 West Bengal98459671202059 Bihar8274154139450 Telangana8075157586637 Gujarat71064542382652 Assam5883842326145 Rajasthan5249738235789 Odisha4592731785321 Haryana4163534781483 Madhya Pradesh3902529020996 Kerala3433121832109 Jammu and Kashmir2489717003472 Punjab2390315319586 Jharkhand185168998177 Chhatisgarh12148880996 Uttarakhand96326134125 Goa871259575 Tripura6161417641 Puducherry5382320187 Manipur3752204411 Himachal Pradesh3371218114 Nagaland30119738 Arunachal Pradesh223115923 Chandigarh1595100425 Meghalaya11154986 Sikkim9105101 Mizoram6203230
  Business   Companies  15 Jul 2020  Zydus begins human trials for potential COVID-19 vaccine

Zydus begins human trials for potential COVID-19 vaccine

REUTERS
Published : Jul 15, 2020, 10:34 am IST
Updated : Jul 15, 2020, 10:34 am IST

In the human trials, Zydus will enrol over 1,000 subjects across multiple clinical study sites in India

 Indian pharmaceutical company Zydus started human studies for its potential COVID-19 vaccine. (AP Photo)
  Indian pharmaceutical company Zydus started human studies for its potential COVID-19 vaccine. (AP Photo)

BENGALURU: Indian pharmaceutical company Zydus said on Wednesday it has started human studies for its potential COVID-19 vaccine, as coronavirus infections continue to surge in the world’s third worst-hit nation.

ZyCoV-D, its plasmid DNA vaccine, was found to be safe, immunogenic and well-tolerated in the pre-clinical toxicity studies, Zydus said.

 

In the human trials, Zydus will enrol over 1,000 subjects across multiple clinical study sites in India.

Tags: india, pharmaceuticals, zydus, covid-19 vaccine, coronavirus
Location: India, Karnataka, Bengaluru